Oncodesign Société Anonyme ALONC.PA Stock
Oncodesign Société Anonyme Price Chart
Oncodesign Société Anonyme ALONC.PA Financial and Trading Overview
| Oncodesign Société Anonyme stock price | 14.42 EUR |
| Previous Close | 14.42 EUR |
| Open | 14.42 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 14.42 - 14.44 EUR |
| 52 Week Range | 7.83 - 14.56 EUR |
| Volume | 90.13K EUR |
| Avg. Volume | 48.4K EUR |
| Market Cap | 99.69M EUR |
| Beta (5Y Monthly) | 1.487804 |
| PE Ratio (TTM) | 46.51613 |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.23 EUR |
ALONC.PA Valuation Measures
| Enterprise Value | 97.68M EUR |
| Trailing P/E | 46.51613 |
| Forward P/E | -43.696968 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.0510716 |
| Price/Book (mrq) | 8.492344 |
| Enterprise Value/Revenue | 2.99 |
| Enterprise Value/EBITDA | -194.093 |
Trading Information
Oncodesign Société Anonyme Stock Price History
| Beta (5Y Monthly) | 1.487804 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 14.56 EUR |
| 52 Week Low | 7.83 EUR |
| 50-Day Moving Average | 14.33 EUR |
| 200-Day Moving Average | 12.11 EUR |
ALONC.PA Share Statistics
| Avg. Volume (3 month) | 48.4K EUR |
| Avg. Daily Volume (10-Days) | 9.01K EUR |
| Shares Outstanding | 6.91M |
| Float | 6.7M |
| Short Ratio | N/A |
| % Held by Insiders | 51.12% |
| % Held by Institutions | 62.83% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -18.94% |
| Operating Margin (ttm) | -6.42% |
| Gross Margin | 46.13% |
| EBITDA Margin | -1.54% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 32.67M EUR |
| Revenue Per Share (ttm) | 4.41 EUR |
| Quarterly Revenue Growth (yoy) | -8.59% |
| Gross Profit (ttm) | 16.07M EUR |
| EBITDA | -503272 EUR |
| Net Income Avi to Common (ttm) | -6188251 EUR |
| Diluted EPS (ttm) | 0.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 1.698 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Oncodesign Société Anonyme
| Country | France |
| State | N/A |
| City | Dijon |
| Address | 20 rue Jean Mazen |
| ZIP | 21076 |
| Phone | 33 3 80 78 82 60 |
| Website | https://www.oncodesign.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 230 |
Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups. It offers integrated drug discovery services; in vitro and in vivo pharmacology services; services for studying the metabolism and pharmacokinetics of drug candidates; and translational biomarkers, biodecontamination/biosafety, and biobanking services. The company also engages in the analysis of new chemical and biological entities, and membrane proteins; and immuno analysis and monitoring, and microbiological monitoring activities. In addition, it engages in the kinase inhibitor development programs, and licensing of Kinase inhibitors in oncology, and CNS and inflammation technologies. Oncodesign Société Anonyme has a strategic partnership with InterSystems for new treatments in the field of oncology; and Covalab. The company also has a collaboration agreement with TiumBio Co., Ltd. for the research and development of fibrosis drug candidates. Oncodesign Société Anonyme was founded in 1995 and is headquartered in Dijon, France.
Q&A For Oncodesign Société Anonyme Stock
What is a current ALONC.PA stock price?
Oncodesign Société Anonyme ALONC.PA stock price today per share is 14.42 EUR.
How to purchase Oncodesign Société Anonyme stock?
You can buy ALONC.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oncodesign Société Anonyme?
The stock symbol or ticker of Oncodesign Société Anonyme is ALONC.PA.
Which industry does the Oncodesign Société Anonyme company belong to?
The Oncodesign Société Anonyme industry is Biotechnology.
How many shares does Oncodesign Société Anonyme have in circulation?
The max supply of Oncodesign Société Anonyme shares is 6.91M.
What is Oncodesign Société Anonyme Price to Earnings Ratio (PE Ratio)?
Oncodesign Société Anonyme PE Ratio is 0.00000000 now.
What was Oncodesign Société Anonyme earnings per share over the trailing 12 months (TTM)?
Oncodesign Société Anonyme EPS is 0 EUR over the trailing 12 months.
Which sector does the Oncodesign Société Anonyme company belong to?
The Oncodesign Société Anonyme sector is Healthcare.